title: Transcatheter Aortic Valve Replacement: 2015 in Review.
abstract: Transcatheter aortic valve replacement (TAVR) has emerged as an attractive option for patients with severe symptomatic aortic stenosis (AS) who are either at high risk or extreme risk for surgical aortic valve replacement (SAVR). This article summarizes the major advances in TAVR that were published or reported in 2015.
authors: Geisinger Clinic, Pearsall Heart Hospital, Wilkes-Barre, Pennsylvania.
authors: Kishore J
authors: KJ
authors: Harjai
authors: Detroit Medical Center Heart Hospital, Detroit, Michigan.
authors: Cindy L
authors: CL
authors: Grines
authors: Columbia University Medical Center, New York, New York.
authors: Martin B
authors: MB
authors: Leon
mesh_terms: D001021:Aortic Valve / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000453:epidemiology / Q000601:surgery; D006350:Heart Valve Prosthesis / Q000639:trends*; D006801:Humans; D000069451:Long Term Adverse Effects / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D020379:Risk Adjustment; D012307:Risk Factors; D012720:Severity of Illness Index; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects / Q000379:methods / Q000639:trends